ATC Abstracts

American Transplant Congress abstracts

2016 American Transplant Congress » Concurrent Session: Kidney Immunosuppression: Novel Agents

Date: Tuesday, June 14, 2016

Time: 2:30pm-4:00pm

Location: Veterans Auditorium

Session Type: Concurrent Session

Meeting: 2016 American Transplant Congress

2:30pm-2:42pm
Polyclonal Treg Adoptive Therapy for Control of Subclinical Kidney Transplant Inflammation (TASK Pilot Trial).

S. Chandran, Q. Tang, M. Sarwal, Z. Laszik, A. Putnam, T. Sigdel, E. Tavares, J. Bluestone, F. Vincenti.

2:42pm-2:54pm
A Molecular Biopsy Test for Probability of Non-Adherence.

P. Halloran,1,3 G. Einecke,2 J. Reeve.1

2:54pm-3:06pm
Blockade of HLA Antibody-Triggered Classical Complement Activation by High-Affinity Humanized Monoclonal Anti-C1s Antibody TNT009 – Results of a First-in-Human Phase 1 Trial.

J. Mühbacher,1 B. Jilma,2 M. Wahrmann,3 L. Marinova,3 F. Eskandary,3 J. Gilbert,4 S. Panicker,4 G. Böhmig.3

3:06pm-3:18pm
Investigating Posttransplant Allo-Donor Specific CD57+ Cells in Patients with Alemtuzumab Induction and Belatacept-Based Regimen.

H. Xu, F. Feng, A. Kirk.

3:18pm-3:30pm
Anti-IL6R Therapy (Tocilizumab) Improves Long-Term Patient & Graft Survival in Patients with Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy.

J. Choi, A. Vo, M. Haas, D. Puliyanda, S. Louie, A. Peng, J. Kahwaji, R. Villicana, I. Kim, J. Mirocha, S. Jordan.

3:30pm-3:42pm
Establishing the Relationship Between Receptor Occupancy, Serum Exposure and Pathway Inhibition by the Blocking, Non-Depleting Anti-CD40 Antibody CFZ533 to Inform Dose Selection in Clinical Transplantation.

P. Espie, J. Munz, T. Flandre, B. Haraldsson, P. Ulrich, J. Rush.

3:42pm-3:54pm
C1-Inhibitor in Acute Antibody-Mediated Rejection Non-Responsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study.

C. Lefaucheur,1 D. Viglietti,1 C. Gosset,1 A. Loupy,2 A. Zeevi,3 D. Glotz.1

« View all sessions from the 2016 American Transplant Congress